Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs

Overview of attention for article published in Annals of the Rheumatic Diseases, August 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 1 news story.

I risultati di uno studio pubblicato online ahead-of-print sulla rivista Annals of Rheumatic Disease hanno dimostrato l'efficacia…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.